10.1186/s13287-017-0694-z Summary Keywords GLP-1, GLP-1RAs, T2DM, glucose, mechanism Citation He X, Zhao W, Li P, Zhang Y, Li G, Su H, Lu B and Pang Z (2025) Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
Patients considering these medications should understand they are being used off-label for this indication, and expectations should be carefully managed regarding potential benefits and limitations
Archives of Dermatological Research
At 1 mg the glucagon receptor sits under 1% occupied, and that sliver is already enough to cut liver fat in half in the people who started with a fatty liver. The 1 mg results show that all three arms are active in obese cohorts
But here's the thing: the same effect that makes you feel full and satisfied is also what causes the side effects
Available at: 12 Garca-CasaresNGonzlez-GonzlezGde la Cruz-CosmeCGarzn-MaldonadoFJde Rojas-LealCArizaMJet al